中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
5期
13-15
,共3页
张开容%谭贵基%区健刚%张永坤%谢锦伟
張開容%譚貴基%區健剛%張永坤%謝錦偉
장개용%담귀기%구건강%장영곤%사금위
VitalStim吞咽障碍治疗仪%吞咽障碍%脑卒中
VitalStim吞嚥障礙治療儀%吞嚥障礙%腦卒中
VitalStim탄인장애치료의%탄인장애%뇌졸중
VitalStim swallowing therapy instrument%Dysphagia%Stroke
目的:探讨VitalStim吞咽障碍治疗仪治疗脑卒中后吞咽障碍的疗效及安全性。方法:将80例脑卒中后吞咽障碍的患者随机分为观察组和对照组,每组各40例,对照组给予常规的脑卒中药物治疗及基础吞咽功能训练和摄食训练。观察组在对照组治疗的基础上加用VitalStim吞咽障碍治疗仪治疗。治疗前后对两组患者进行吞咽功能评级,并观察临床疗效以及不良反应。结果:治疗后两组患者吞咽功能均较治疗前改善,治疗后观察组吞咽功能明显优于对照组,差异均有统计学意义(P<0.05)。两组临床疗效比较,观察组总有效率为90.0%,对照组总有效率为72.5%,观察组疗效优于对照组,两组比较差异有统计学意义(P<0.05)。两组均无明显不良反应。结论:VitalStim吞咽障碍治疗仪治疗脑卒中后吞咽障碍疗效显著,且无不良反应,值得在临床中推广应用。
目的:探討VitalStim吞嚥障礙治療儀治療腦卒中後吞嚥障礙的療效及安全性。方法:將80例腦卒中後吞嚥障礙的患者隨機分為觀察組和對照組,每組各40例,對照組給予常規的腦卒中藥物治療及基礎吞嚥功能訓練和攝食訓練。觀察組在對照組治療的基礎上加用VitalStim吞嚥障礙治療儀治療。治療前後對兩組患者進行吞嚥功能評級,併觀察臨床療效以及不良反應。結果:治療後兩組患者吞嚥功能均較治療前改善,治療後觀察組吞嚥功能明顯優于對照組,差異均有統計學意義(P<0.05)。兩組臨床療效比較,觀察組總有效率為90.0%,對照組總有效率為72.5%,觀察組療效優于對照組,兩組比較差異有統計學意義(P<0.05)。兩組均無明顯不良反應。結論:VitalStim吞嚥障礙治療儀治療腦卒中後吞嚥障礙療效顯著,且無不良反應,值得在臨床中推廣應用。
목적:탐토VitalStim탄인장애치료의치료뇌졸중후탄인장애적료효급안전성。방법:장80례뇌졸중후탄인장애적환자수궤분위관찰조화대조조,매조각40례,대조조급여상규적뇌졸중약물치료급기출탄인공능훈련화섭식훈련。관찰조재대조조치료적기출상가용VitalStim탄인장애치료의치료。치료전후대량조환자진행탄인공능평급,병관찰림상료효이급불량반응。결과:치료후량조환자탄인공능균교치료전개선,치료후관찰조탄인공능명현우우대조조,차이균유통계학의의(P<0.05)。량조림상료효비교,관찰조총유효솔위90.0%,대조조총유효솔위72.5%,관찰조료효우우대조조,량조비교차이유통계학의의(P<0.05)。량조균무명현불량반응。결론:VitalStim탄인장애치료의치료뇌졸중후탄인장애료효현저,차무불량반응,치득재림상중추엄응용。
Objective:To investigate the efficacy and safety of theVitalStim swallowing therapy instrument in the treatment of dysphagia after stroke.Method:80 patients with dysphagia after stroke were randomly divided into observation group and control group,40 cases in each group.The control group was given conventional stroke medcine therapy and basic swallowing function training and feeding training.The observation group was added VitalStim swallowing therapy instrument based on the treatment in control group.The swallowing functional rating,the clinical effect and adverse reaction were observed before and after treatment in two groups.Result:After treatment,the swallowing function of two groups were improved compared with before treatment,the swallowing function of the observation group was significantly better than that of the control group,the differences were statistically significant(P<0.05). The total effective rate was 90%of observation group,better than 72.5%of control group,the difference was statistically significant(P<0.05). There were no obvious adverse reaction in two groups.Conclusion:VitalStim swallowing therapy instrument has significantly curative effect in the treatment of dysphagia after stroke,and no adverse reaction.It is worth in clinical application.